Ting He

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

Zhitao Ying, Ting He, Xiaopei Wang et al. · Molecular Therapy — Oncolytics · 2019 · 167 citations · Full text

Medicine, Immunology, Oncology +16

The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing

Liren Qian, Dan Li, Lie Ma et al. · Cellular Immunology · 2016 · 35 citations

Life Sciences, Immunology, Oncology +16

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

Zhitao Ying, Ting He, Xiaopei Wang et al. · BMC Cancer · 2021 · 26 citations · Full text

Medicine, Immunology, Oncology +12

Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial

Shengnan Yue, Ting He, Baiyang Li et al. · Trials · 2019 · 11 citations · Full text

Medicine, Geriatric Medicine, Neurology +16

Antigen-independent activation is critical for the durable antitumor effect of GUCY2C-targeted CAR-T cells

Changsong Qi, D Y Liu, Chang Liu et al. · Journal for ImmunoTherapy of Cancer · 2024 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17